Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
6.83
+0.04 (0.59%)
At close: Feb 20, 2026, 4:00 PM EST
6.82
-0.01 (-0.15%)
After-hours: Feb 20, 2026, 5:09 PM EST

Puma Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
344150206196124408
Market Cap Growth
148.68%-27.32%5.07%57.73%-69.53%19.67%
Enterprise Value
291139233233154420
Last Close Price
6.833.054.334.233.0410.26
PE Ratio
9.184.959.5498021.07--
Forward PE
16.6611.6210.5733.92--
PS Ratio
1.620.650.870.860.491.81
PB Ratio
2.991.633.859.07-50.81-68.55
P/TBV Ratio
4.823.65----
P/FCF Ratio
8.033.857.67-6.02561.16
P/OCF Ratio
8.013.857.63-6.02527.77
EV/Sales Ratio
1.370.610.991.020.611.86
EV/EBITDA Ratio
6.513.285.215.7412.22-
EV/EBIT Ratio
8.674.507.017.58119.32-
EV/FCF Ratio
6.783.598.68-7.45577.31
Debt / Equity Ratio
0.360.802.095.29-47.69-20.32
Debt / EBITDA Ratio
0.861.612.272.546.78-
Debt / FCF Ratio
0.961.914.15-5.65166.37
Net Debt / Equity Ratio
-0.46-0.290.291.54-14.12-4.63
Net Debt / EBITDA Ratio
-1.19-0.630.350.822.74-1.35
Net Debt / FCF Ratio
-1.24-0.690.58-2.101.6737.92
Asset Turnover
1.001.041.041.021.080.94
Inventory Turnover
8.068.1510.809.4712.0611.89
Quick Ratio
1.551.381.451.591.051.04
Current Ratio
1.741.541.571.731.281.28
Return on Equity (ROE)
39.68%41.60%57.54%0.02%--1042.30%
Return on Assets (ROA)
9.90%8.72%9.19%8.56%0.34%-7.93%
Return on Invested Capital (ROIC)
56.00%46.14%51.17%0.31%4.80%-127.57%
Return on Capital Employed (ROCE)
27.90%26.40%25.40%21.20%1.10%-23.40%
Earnings Yield
10.74%20.22%10.48%0.00%-23.43%-14.71%
FCF Yield
12.46%25.96%13.04%-8.07%16.61%0.18%
Buyback Yield / Dilution
-2.69%-3.26%-5.83%-10.56%-2.69%-2.08%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q